Peptide Decoding
New?New to peptides?Start here →
Decoding

Cerebrolysin_Dosage, benefits & legal status

Also known as FPF-1070

Published July 22, 2026 · Updated September 22, 2026

An injectable brain-peptide blend used abroad for stroke and dementia recovery.

Brain recoveryBrain peptide mixtureClinical use
Common vial size60 mg
Dose10 up to 50 mL per day (start low, increase slowly)
Frequency10-20 day cycles
RouteInto muscle or a vein
StatusApproved abroad, not FDA approved
Cycled10 to 21 day courses of daily infusion, repeated after roughly two months

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Cerebrolysin?

Plain language first. The technical label stays, but it never stands alone.

Overview

Injected in cycles, it feeds and protects brain cells. It has the strongest human evidence in this group, for stroke and dementia recovery.

The technical version

Cerebrolysin is a mixture of small peptides and amino acids extracted from pig brain tissue, rich in nerve-growth signals.

What it's used for

An injectable brain-peptide blend with the strongest human evidence in this group, used abroad for stroke, dementia, and brain-injury recovery. It is given in cycles.

02

How does Cerebrolysin work?

What it does in the body, and where.

Cerebrolysin is not one peptide but a mixture, extracted from pig brain tissue and broken into small fragments.

  1. 01
    It supplies nerve growth and protection signals
    The mixture contains fragments that mimic neurotrophic factors, the proteins that keep brain cells alive and connected.
  2. 02
    It is given in cycles, by infusion or injection
    Typically daily for several weeks, then a break, rather than continuously.
  3. 03
    It has genuine human trial evidence
    Uncommon in this category. It has been studied in stroke, traumatic brain injury, and dementia, with modest and debated results.
  4. 04
    Being an animal-derived mixture, batches vary
    And the exact composition is not fully characterized, which is a real limitation on interpreting any of the trials.
Anatomical illustration highlighting brain
WHERE THIS COMPOUND IS THOUGHT TO ACT:
Brain

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Stroke recovery, where it is used clinically in parts of Europe and AsiaClinical use
  • Dementia and Alzheimer's diseaseClinical use
  • Traumatic brain injury recoveryClinical use

The published record

Research index

710

Papers and trials about Cerebrolysin

Searched: Cerebrolysin, FPF-1070.

249 papers tagged human · 141 not reviews or lab · 56 clinical trial publications

43 registered trials · 3 with posted results

Furthest stage reached: Approved outside the US, 45+ countries

Compare this against the whole library →

In animals167
In the lab14
Reviews82
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 441 papers and 43 trials indexed in detail.

Cerebrolysin vial rendering
Compound field notes

At a glance

Four things to know about Cerebrolysin

01

Evidence

Clinical use

02

Category

Healing and recovery

03

Common vial

60 mg

04

Half-life

Not a single number

04

How much, and do you cycle it?

The range, and whether you take breaks.

10 up to 50 mL per day (start low, increase slowly), 10-20 day cycles. 10 to 21 day courses of daily infusion, repeated after roughly two months Trial dose

The course structure here is real and documented, unlike most course-based compounds on this site. Stroke trials used 21 consecutive days; the vascular dementia trial ran four weeks then repeated after a two-month treatment-free gap. Both the course and the gap come from registered trials.

Source: Cerebrolysin in vascular dementia: 4-week course repeated after a 2-month interval (NCT00947531)

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not a single numberCommunity practice

Cerebrolysin is a mixture of peptides and amino acids from pig brain rather than one molecule, so a single half-life would not mean much. The 2.5 to 6 hours quoted online traces to no primary source.

Not yet traced to a primary source.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 10 up to 50 mLTrial dose

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW33.3 / 100 units
What it costs

Cerebrolysin starts at $31.20 across 21 vendors, typically $0.52 – $1.83 per mg.

21 listings, last read Oct 24, 2026. Shipping and card fees are not included.

See all 21 listings →
07

How do you store it?

Before mixing, and after.

Follow the storage on the product label.

Cerebrolysin is supplied as a finished product, so its label sets the storage. Pens, prefilled syringes, implants, tablets and ready-made solutions are used as supplied. Kits that include a powder are mixed just before the dose and usually used straight away, not kept for weeks. Many injectable products go in the fridge and must not be frozen, while others are kept at room temperature, so check the pack or ask the pharmacist.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Epilepsy or a seizure disorder
  • Allergy to pork, since it is derived from pig brain tissue
  • Severe kidney impairment
  • Pregnancy

Stop and get help

These are emergencies. Seek care.
  • A seizure
  • Signs of an allergic reaction such as face or throat swelling or trouble breathing

Common effects

Expected, and usually mild.
  • Warmth or flushing if injected too quickly
  • Dizziness
  • Injection-site reactions
  • Counterfeits are common, so verify the source

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Cerebrolysin approved?

And where the numbers on this page come from.

Not in the United States. Cerebrolysin has no FDA approval. It is approved in 45+ countries.

  • Approval status
    Clinical use
  • Route
    Into muscle or a vein
  • Checked
    22 September 2026
  • Approved outside the US
    45+ countries: Approved for stroke in more than 45 countries, including Austria, Russia and China. The marketing authorisation is held by EVER Neuro Pharma in Austria, and the label covers stroke, dementia and head injury. Not approved in the US.This does not change the United States position above.
  • Dose
    From published clinical trials. Not approved by a regulator for this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

Used clinically in parts of Europe and Asia in treatment cycles. Not FDA-approved. Counterfeits are widely reported, so source verification matters more than usual.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 484 records are indexed. Browse the records